Terms: = Thyroid cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Treatment
41 results:
1. Asiaticoside Down-Regulates HIF-1α to Inhibit Proliferation, Migration, and Angiogenesis in thyroid cancer Cells.
Zhang Y; Han Y; Dong J; Li F; Sun Y
Balkan Med J; 2024 Jan; 41(1):23-29. PubMed ID: 38044598
[TBL] [Abstract] [Full Text] [Related]
2. HIF-1α regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF-κB signaling pathway.
Wang D; Liu X; Li M; Ning J
Mol Carcinog; 2024 Feb; 63(2):238-252. PubMed ID: 37861358
[TBL] [Abstract] [Full Text] [Related]
3. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
4. Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance.
Trocchianesi S; Po A; Citarella A; Spinello Z; Rughetti A; Besharat ZM; Autilio TM; Pecce V; Verrienti A; Elisei R; Durante C; Catanzaro G; Ferretti E
Biomed Pharmacother; 2023 Aug; 164():114995. PubMed ID: 37301138
[TBL] [Abstract] [Full Text] [Related]
5. Isoproterenol-induced Upregulation of HPSE Accelerates Triple-negative Breast cancer Cell Proliferation and Migration through Enhancing the Transcriptional Activity of HIF-1α.
Qiu J; Shen Z; Jiang G; Ni Q
Anticancer Agents Med Chem; 2023; 23(4):470-477. PubMed ID: 35980070
[TBL] [Abstract] [Full Text] [Related]
6. KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway.
Zhang W; Ruan X; Li Y; Zhi J; Hu L; Hou X; Shi X; Wang X; Wang J; Ma W; Gu P; Zheng X; Gao M
Theranostics; 2022; 12(4):1500-1517. PubMed ID: 35198054
[No Abstract] [Full Text] [Related]
7. A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery.
Liu W; Ye X; He L; Cheng J; Luo W; Zheng M; Hu Y; Zhang W; Cao Y; Ran H; Yang L
J Nanobiotechnology; 2021 Dec; 19(1):432. PubMed ID: 34930301
[TBL] [Abstract] [Full Text] [Related]
8. Apigenin increases radiosensitivity of glioma stem cells by attenuating HIF-1α-mediated glycolysis.
Zhao Y; Huang H; Jia CH; Fan K; Xie T; Zhu ZY; Xie ML
Med Oncol; 2021 Sep; 38(11):131. PubMed ID: 34554338
[TBL] [Abstract] [Full Text] [Related]
9. The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis.
Zheng F; Chen J; Zhang X; Wang Z; Chen J; Lin X; Huang H; Fu W; Liang J; Wu W; Li B; Yao H; Hu H; Song E
Nat Commun; 2021 Feb; 12(1):1341. PubMed ID: 33637716
[TBL] [Abstract] [Full Text] [Related]
10. Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF-1α regulator.
Isomura H; Taguchi A; Kajino T; Asai N; Nakatochi M; Kato S; Suzuki K; Yanagisawa K; Suzuki M; Fujishita T; Yamaguchi T; Takahashi M; Takahashi T
Cancer Sci; 2021 Apr; 112(4):1614-1623. PubMed ID: 33506575
[TBL] [Abstract] [Full Text] [Related]
11. HIF-1α-Mediated Telomerase Reverse Transcriptase Activation Inducing Autophagy Through Mammalian Target of Rapamycin Promotes Papillary thyroid Carcinoma Progression During Hypoxia Stress.
Song H; Chen X; Jiao Q; Qiu Z; Shen C; Zhang G; Sun Z; Zhang H; Luo QY
Thyroid; 2021 Feb; 31(2):233-246. PubMed ID: 32772829
[No Abstract] [Full Text] [Related]
12. Effects of metformin and pioglitazone combination on apoptosis and AMPK/mTOR signaling pathway in human anaplastic thyroid cancer cells.
Ozdemir Kutbay N; Biray Avci C; Sarer Yurekli B; Caliskan Kurt C; Shademan B; Gunduz C; Erdogan M
J Biochem Mol Toxicol; 2020 Oct; 34(10):e22547. PubMed ID: 32589349
[TBL] [Abstract] [Full Text] [Related]
13. Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1
Zhou Y; Dong X; Xiu P; Wang X; Yang J; Li L; Li Z; Sun P; Shi X; Zhong J
Oxid Med Cell Longev; 2020; 2020():7079308. PubMed ID: 32273947
[TBL] [Abstract] [Full Text] [Related]
14. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.
Feng J; Dai W; Mao Y; Wu L; Li J; Chen K; Yu Q; Kong R; Li S; Zhang J; Ji J; Wu J; Mo W; Xu X; Guo C
J Exp Clin Cancer Res; 2020 Jan; 39(1):24. PubMed ID: 32000827
[TBL] [Abstract] [Full Text] [Related]
15. FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
Watanabe A; Harimoto N; Yokobori T; Araki K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Yamanaka T; Handa T; Oyama T; Higuchi T; Shirabe K
Int J Clin Oncol; 2020 Feb; 25(2):322-329. PubMed ID: 31612350
[TBL] [Abstract] [Full Text] [Related]
16. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
[TBL] [Abstract] [Full Text] [Related]
17. High-Mobility Group Box 1 (HMGB1) Promotes Angiogenesis and Tumor Migration by Regulating Hypoxia-Inducible Factor 1 (HIF-1α) Expression via the Phosphatidylinositol 3-Kinase (PI3K)/AKT Signaling Pathway in Breast cancer Cells.
He H; Wang X; Chen J; Sun L; Sun H; Xie K
Med Sci Monit; 2019 Apr; 25():2352-2360. PubMed ID: 30930461
[TBL] [Abstract] [Full Text] [Related]
18. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast cancer.
Liu MM; Li Z; Han XD; Shi JH; Tu DY; Song W; Zhang J; Qiu XL; Ren Y; Zhen LL
Sci Rep; 2017 Nov; 7(1):15929. PubMed ID: 29162879
[TBL] [Abstract] [Full Text] [Related]
19. Activation of hypoxia-inducible factor-1α by prolonged in vivo hyperinsulinemia treatment potentiates cancerous progression in estrogen receptor-positive breast cancer cells.
Wang L; Fan J; Yan CY; Ling R; Yun J
Biochem Biophys Res Commun; 2017 Sep; 491(2):545-551. PubMed ID: 28351619
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological Features and Prognosis of Papillary thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract] [Full Text] [Related]
[Next]
